-
41
المؤلفون: Ian W. Flinn, Ksenia Titorenko, Carla Boquimpani, Gabriel Etienne, Richard E. Clark, Israel Bendit, Surapol Issaragrisil, Richard A. Larson, Timothy P. Hughes, Dong-Wook Kim, Andreas Hochhaus, Maria Aparecida Zanichelli, Slawomira Kyrcz-Krzemien, Silvia Cacciatore, Giuseppe Saglio, Hagop M. Kantarjian, Ewa Medras, Paola Aimone, Philipp le Coutre, Viviane Dubruille, Ricardo Pasquini
المصدر: Leukemia. 35:2142-2143
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Myeloid leukemia, Imatinib, Hematology, Newly diagnosed, medicine.disease, Leukemia, Nilotinib, Internal medicine, medicine, Long term outcomes, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ae87a9c2b6125fef080a83a755f1e04dTest
https://doi.org/10.1038/s41375-021-01306-1Test -
42
المؤلفون: Carla Boquimpani, Gabriel Etienne, Israel Bendit, Philipp le Coutre, Ksenia Titorenko, Timothy P. Hughes, Ewa Medras, Viviane Dubruille, Silvia Cacciatore, Paola Aimone, Hagop M. Kantarjian, Ricardo Pasquini, Giuseppe Saglio, Dong-Wook Kim, Slawomira Kyrcz-Krzemien, Richard E. Clark, Maria Aparecida Zanichelli, Andreas Hochhaus, Surapol Issaragrisil, Richard A. Larson, Ian W. Flinn
المصدر: Leukemia
مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Context (language use), Newly diagnosed, Article, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, Long term outcomes, medicine, Humans, Adverse effect, neoplasms, Chronic myeloid leukaemia, Haematological cancer, Framingham Risk Score, business.industry, Myeloid leukemia, Correction, Imatinib, Hematology, Middle Aged, Prognosis, Survival Rate, Pyrimidines, Nilotinib, Imatinib Mesylate, Female, business, medicine.drug, Follow-Up Studies
وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f51ac7fae4b80e1587ed6dbe67919d6Test
https://pubmed.ncbi.nlm.nih.gov/34108614Test -
43
المؤلفون: Clarissa Heck (11498440), Sophie Steiner (7865177), Eva M. Kaebisch (11498443), Marco Frentsch (10677069), Friedrich Wittenbecher (11498446), Carmen Scheibenbogen (358526), Leif G. Hanitsch (7010120), Axel Nogai (3506435), Philipp le Coutre (11498449), Lars Bullinger (2736118), Igor-Wolfgang Blau (11498452), Il-Kang Na (214862)
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, B cell defects, autologous hematopoiectic stem cell transplantation, T cell dependent B cell activation, immune reconstitution, multiple myeloma, secondary immunodeficiencies
-
44
المؤلفون: Nadine Lackamp (11651695), Ina Wilkemeyer (11651698), Ivan Jelas (11651701), Ulrich Keller (163515), Lars Bullinger (2736118), Sebastian Stintzing (3642580), Philipp le Coutre (11498449)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, sperm cryopreservation, fertility preservation, assisted reproduction techniques (ART), natural fertility, reproductive outcomes, cancer treatment
-
45
المؤلفون: Nadine Lackamp (11651695), Ina Wilkemeyer (11651698), Ivan Jelas (11651701), Ulrich Keller (163515), Lars Bullinger (2736118), Sebastian Stintzing (3642580), Philipp le Coutre (11498449)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, sperm cryopreservation, fertility preservation, assisted reproduction techniques (ART), natural fertility, reproductive outcomes, cancer treatment
-
46
المؤلفون: Naeem Chaudhri, Michael J. Mauro, Koji Sasaki, Sergey Voloshin, Dennis Dong Hwan Kim, Valentín García Gutiérrez, Timothy P. Hughes, Carla Boquimpani, Lynette C.Y. Chee, Jorge E. Cortes, Anna G. Turkina, Sarah Quenet, Andre Abdo, Andreas Hochhaus, Shruti Kapoor, Yosuke Minami, Jane F. Apperley, Susanne Saussele, Dong-Wook Kim, Laura Fogliatto, Delphine Rea, Véronique Bédoucha, Mario Annunziata, Elza Lomaia, Philipp le Coutre, Alex Allepuz
المصدر: Blood. 138:310-310
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Myeloid leukemia, Phases of clinical research, Cell Biology, Hematology, Biochemistry, Internal medicine, medicine, In patient, Open label, business, Bosutinib, Tyrosine kinase, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7dd81eaa120fe3ae5a6bf3d8985e98e2Test
https://doi.org/10.1182/blood-2021-152561Test -
47
المؤلفون: Philipp le Coutre, Rocco Piazza, Carlo Gambacorti-Passerini
المساهمون: Gambacorti-Passerini, C, Coutre, P, Piazza, R
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, treatment selection, Fusion Proteins, bcr-abl, bosutinib, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Quality of life, chronic myeloid leukemia, MED/15 - MALATTIE DEL SANGUE, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Nitriles, Humans, Medicine, first-line, Adverse effect, Protein Kinase Inhibitors, Aniline Compounds, business.industry, later-line, Myeloid leukemia, General Medicine, Clinical trial, Treatment Outcome, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Concomitant, Quinolines, business, Bosutinib, 030215 immunology, medicine.drug, Patient education
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444cb2a2eb4678dfd3f2dfeedba05bf1Test
http://hdl.handle.net/10281/259690Test -
48
المؤلفون: Silvia Mori, Bruno Martino, Sarit Assouline, Micaela Bergamaschi, Eros Di Bona, Marcio Andrade-Campos, Chiara Elena, Patrizia Crivori, Ester Pungolino, Alessandra Iurlo, Antonella Gozzini, Philipp le Coutre, Elisa Diral, Elisabetta Abruzzese, Laura Antolini, Alessandra Pirola, Diletta Fontana, Fabio Stagno, Maria Luisa Bonanomi, Rocco Piazza, Carmen Fava, Carlo Gambacorti-Passerini, Jessica Petiti
المساهمون: Diral, E, Mori, S, Antolini, L, Abruzzese, E, Le Coutre, P, Martino, B, Pungolino, E, Elena, C, Bergamaschi, M, Assouline, S, Di Bona, E, Gozzini, A, Andrade-Campos, M, Stagno, F, Iurlo, A, Pirola, A, Fontana, D, Petiti, J, Bonanomi, M, Crivori, P, Piazza, R, Fava, C, Gambacorti Passerini, C
مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Adolescent, Immunology, Tumor burden, Antineoplastic Agents, Biochemistry, Young Adult, chronic myeloid leukemia, MED/15 - MALATTIE DEL SANGUE, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Recurrence free survival, Internal medicine, medicine, Humans, In patient, Aged, Aged, 80 and over, business.industry, Myeloid leukemia, Imatinib, clinical trial, Cell Biology, Hematology, Middle Aged, Prognosis, BCR-ABL protein, Tumor Burden, Discontinuation, Survival Rate, Withholding Treatment, Imatinib Mesylate, Female, business, Follow-Up Studies, Cohort study, medicine.drug, discontinuation
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373ab22048a187785430319d1067b850Test
http://hdl.handle.net/10281/315442Test -
49
المؤلفون: Véronique Bédoucha, Norbert Gattermann, Philipp le Coutre, Prashanth Gopalakrishna, Jerald P. Radich, Weiping Deng, Susanne Saussele, Eibhlin Conneally, Nancy Krunic, Giuseppe Saglio, Andrzej Hellmann, Bruno Martino, Francis J. Giles, Valentín García-Gutiérrez, Tamás Masszi, David M. Ross, María Teresa Gómez Casares, Jesper Stentoft, Andreas Hochhaus
المصدر: Journal of Cancer Research and Clinical Oncology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Ross, D M, Masszi, T, Gómez Casares, M T, Hellmann, A, Stentoft, J, Conneally, E, Garcia-Gutierrez, V, Gattermann, N, le Coutre, P D, Martino, B, Saussele, S, Giles, F J, Radich, J P, Saglio, G, Deng, W, Krunic, N, Bédoucha, V, Gopalakrishna, P & Hochhaus, A 2018, ' Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib : 96-week update of the ENESTfreedom study ', Journal of Cancer Research and Clinical Oncology, vol. 144, no. 5, pp. 945-954 . https://doi.org/10.1007/s00432-018-2604-xTestمصطلحات موضوعية: Oncology, Male, Cancer Research, Predictors of TFR, Time Factors, Original Article – Clinical Oncology, Kaplan-Meier Estimate, 0302 clinical medicine, Treatment-free remission, hemic and lymphatic diseases, 80 and over, Medicine, Young adult, Chronic, Aged, 80 and over, Hematology, Leukemia, Chronic myeloid leukemia, Remission Induction, Myeloid leukemia, General Medicine, Middle Aged, Protein-Tyrosine Kinases, Clinical trial, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, 03 medical and health sciences, Young Adult, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Humans, In patient, Frontline, Adverse effect, Aged, business.industry, Nilotinib, Pyrimidines, Major Molecular Response, BCR-ABL Positive, business, 030215 immunology, Myelogenous
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2d4ac03af448129196634e600efcb4Test
http://europepmc.org/articles/PMC5916993Test -
50
المؤلفون: Massimo Breccia, Michael Mauro, Elias Jabbour, Giuseppe Saglio, Antonio Jiménez-Velasco, Philipp le Coutre, Irene DeGutis, Wasiulla Khan, Oumar Sy, Rene Swanink, Jorge E. Cortes
المصدر: Clinical Lymphoma Myeloma and Leukemia. 21:S223
مصطلحات موضوعية: Cancer Research, Oncology, Hematology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::45794c3c3b9df096fedb1502fac149e8Test
https://doi.org/10.1016/s2152-2650Test(21)01406-3